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Incidentalomas during imaging for primary
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clinical outcomes
P. Prasad1,3*, C. Clout2, E. Lorenz2, B. J. Harrison1 and S. P. Balasubramanian1,3
Abstract
Background: Imaging for pre-operative localisation of parathyroid glands in primary hyperparathyroidism is now
routine. This has led to the detection of incidental lesions (incidentalomas) in other organs, the nature of which is
not well characterised.
The aim of this study was to determine the incidence, characteristics and outcomes in patients who had incidental
findings on parathyroid imaging.
Methods: Records of patients who underwent imaging for primary hyperparathyroidism over 2 years were reviewed
to identify incidental lesions detected on parathyroid imaging. Patients with persistent or renal hyperparathyroidism
were excluded. Details on the management of detected incidentalomas were obtained from patient records.
Results: Incidentalomas were identified in 17 of 170 patients (10 %) undergoing parathyroid imaging. Incidentalomas
included thyroid (n = 11), breast (n = 3), lateral compartment of the neck (n= 1), lung (n = 1) and clavicle (n = 1). However,
no disease of clinical significance needing treatment was detected on further investigation.
Conclusions: Although a significant proportion of patients undergoing parathyroid imaging had incidental lesions
detected, these seem to be of little clinical significance. The morbidity and cost of further interventions on these
incidentalomas need to be weighed against the benefits of routine imaging in improving outcomes of first-time
surgery in patients with primary hyperparathyroidism.
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Background
Primary hyperparathyroidism (pHPT) is a common
cause of hypercalcaemia and the third most frequently
diagnosed endocrine disorder [1–3]. It occurs as a result
of one or more overactive parathyroid glands; single-gland
disease accounts for the majority of cases [2–5]. Whilst
bilateral neck exploration used to be the mainstay of
surgical treatment, minimally invasive surgical options are
increasingly adopted [3–7]. Minimally invasive surgery
relies on accurate pre-operative localisation of the abnor-
mal gland(s). Technetium99 sestamibi (Tc99m MIBI) and
cervical ultrasound (USS) are the most widely used
investigations for pre-operative parathyroid localisation.
The use of pre-operative imaging in pHPT has led to
the increased detection of incidentally detected lesions
or ‘incidentalomas’ in other organs. For example, ultra-
sound can detect co-existing thyroid nodules as the
thyroid gland is routinely evaluated in parathyroid im-
aging [5, 8]. Detection of these and other lesions else-
where could lead to further investigations and surgery.
The benefits of these interventions to the patient are
debatable. Moreover, the results of imaging studies have
the potential to delay parathyroid surgery and this may
contribute to increased morbidity.
A series of such incidental lesions detected at this institu-
tion led to the initiation of this study. The aim of this study
was to determine the incidence, management and clinical
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outcomes of incidentally detected lesions identified during
pHPT imaging.
The objectives of the study were as follows:
1. Determine the incidence of incidentalomas during
imaging for pHPT in a tertiary care institution over
a 2-year period.
2. Identify the management strategies adopted and
clinical outcomes following treatment of these
incidentally detected lesions.
3. Evaluate any differences in length of waiting for
parathyroidectomy amongst patients with and
without incidentalomas.
Methods
This was a retrospective cohort study. All patients who
had a Tc99m MIBI and/or USS performed for parathy-
roid localisation prior to first-time surgery for pHPT
between January 2010 and December 2011 at Sheffield
Teaching Hospitals NHS Foundation Trust were in-
cluded in this study.
The reports of Tc99m MIBI and USS scans in patients
with pHPT were reviewed by one author (PP). Patients
undergoing parathyroid imaging for persistent pHPT or
renal hyperparathyroidism and patients who had under-
gone imaging in other hospitals were excluded. Any
uncertainties regarding eligibility for inclusion into the
study were discussed with the lead author (SPB). Data on
the identification and lateralisation of enlarged glands and
on the presence and nature of any incidental lesions iden-
tified was collected from radiology reports. A new finding
unrelated to parathyroid pathology was deemed to be an
‘incidentaloma’ based on the reporting radiologist’s inter-
pretation of the finding and on whether he/she had noted
sufficient concern to warrant further investigation.
Further information on investigations performed for
the incidentalomas, the results of these investigations,
management strategies, relevant clinical outcomes and
time taken from initial parathyroid imaging to surgery
was retrieved from electronic and/or paper records. The
Mann-Whitney U test was utilised to determine if there
was a statistically significant difference in waiting times
between patients with and without incidentalomas.
The proposal for the study was approved by the trust’s
Clinical Effectiveness Unit.
Results
One hundred eighty-nine patients underwent parathy-
roid gland localisation scans between January 2010 and
December 2011. Figure 1 demonstrates the process of
inclusion of patients and the number and type of inci-
dentalomas detected in this study.
The mean (standard deviation) age of the patients
included in this study was 61(15.7) years. Most patients
were females (114 or 67.1 % of the study population).
Seventeen of the 170 patients (10 %) undergoing
imaging for pHPT had incidental lesions identified.
Twelve of these were identified on ultrasound, and five
were detected by a Tc99m MIBI scan. There was no
concordance between the imaging modalities for any
incidental lesion identified.
Eleven patients had thyroid nodules incidentally de-
tected by ultrasound, that radiologists suggested re-
quired further investigation or monitoring. Six of these
patients underwent an USS-guided fine-needle aspir-
ation (FNA) of the thyroid nodule. Cytology from the
FNA was benign in five patients and indeterminate in one
patient. The patient with the indeterminate result had a
lobectomy, the histology of which was benign. A total of
four patients had the thyroid gland examined macros-
copically at parathyroidectomy and had nodules excised
or a lobectomy performed. Table 1 summarises the histo-
logical findings from the excised thyroid tissue in the five
patients (macroscopic thyroid gland examination n = 4;
lobectomy for indeterminate thyroid nodule n = 1) who
underwent surgery. One patient had a 1.5-mm papillary
microcancer detected histologically in a specimen that
was predominantly a colloid goitre. One patient with a
thyroid incidentaloma was managed conservatively; a
follow-up ultrasound did not demonstrate any change to
the incidental thyroid lesion.
Of the three patients with incidental breast lesions on
MIBI scan, one patient had a breast ultrasound, one
patient had a mammogram and one patient underwent
both forms of imaging. No malignant features were identi-
fied in any patient, and none were subjected to biopsy.
Three patients had lesions detected elsewhere in the
body. One patient had an enlarged cervical lymph node
identified on ultrasound. Cytology from ultrasound-
guided aspiration showed low-grade lymphoproliferative
disease. As the patient was already under the care of
haematologists for indolent non-Hodgkin’s lymphoma at
the time of the scan, no further action was taken. The
second patient had a lesion identified in the right lung on
MIBI scan. CT thorax/abdomen and a PET scan con-
firmed an indeterminate lung nodule, thought to be a
neuroendocrine tumour. The patient is being monitored
by annual imaging. The third patient had increased
uptake in the left clavicle on MIBI and underwent an
X-ray. This demonstrated a normal bony appearance,
and no further investigation or treatment was performed.
The median (interquartile range) waiting time for
parathyroid surgery for patients with and without
incidentalomas was 6.4 (3.5–7.0) and 5 (3.1–7.3)
months, respectively; this was not statistically signifi-
cant (p = 0.398).
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Discussion
Advancements in modern imaging and surgical tech-
niques have enabled surgeons to adopt a minimally inva-
sive approach in the treatment of many patients with
pHPT [3, 9]. The success of such surgical approaches is
largely dependent on accurate pre-operative localization
of the overactive parathyroid gland(s) [7, 10]. One of the
disadvantages of imaging is the detection of incidental
lesions elsewhere in the body. Such lesions may require
further investigation and treatment, potentially predis-
posing them to increased morbidity and delaying treat-
ment of the primary condition for which imaging was
requested. In the setting of parathyroid gland imaging
for adenoma localisation, there is a gap identified in the
literature on the incidence and risks of incidentalomas,
nature of such lesions, their investigation and management.
The 10 % incidentaloma rate reported in our study is
likely to be an underestimate. The vast majority of
reporting was done by experienced consultant radiolo-
gists who have a special interest in parathyroid imaging.
Thyroid nodules are commonly detected during ultra-
sound; however, only those that had equivocal or suspi-
cious findings on imaging were highlighted by the
radiologist and investigated further. Similarly, for MIBI
Fig. 1 Flow chart depicting the flow of patients in this study. Out of 189 patients, 19 were excluded as they did not meet the inclusion criteria for the
study. Out of the 170 patients included in the study, incidentalomas were detected on ultrasound (n = 12) or MIBI (n = 5) alone. Sites of the incidentalomas
include the thyroid gland (n = 11), breast (n = 3), lymph node (n = 1), clavicle (n = 1) and lung (n = 1). There was no concordance between the imaging
modalities for any incidental lesion identified
Table 1 Histology results of surgically excised thyroid tissue
Histology Number of patients
Florid Hashimoto’s thyroiditis 1
Moderate thyroiditis 1
Multinodular goitre 1
Colloid goitre with incidental 1.5-mm
papillary microcancer
1
Benign appearance of thyroid tissue 1
Data illustrates the histology results of the thyroid tissue excised during surgery for primary hyperparathyroidism
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reports, uptakes within physiological limits at other sites
were not considered to be ‘incidentalomas’. Despite the
careful selection of ‘incidentalomas’ in this study, the
results have demonstrated that there was no pathology
of major clinical significance identified on further assess-
ment. Whilst the cohort size is small, the benign nature
of the incidentalomas detected in this study may help
reassure both patients and clinicians that most of these
lesions do not tend to be of clinical concern.
Ultrasound for parathyroid localisation has led to the
detection of concomitant thyroid pathology. The inci-
dence, nature and suggestions for management of the
incidentally detected thyroid nodule during parathyroid
imaging have been well documented in the literature
[5, 8, 11, 12]. However, there has been no study to
our knowledge that examines the incidence, nature and
management of extra-cervical incidentalomas identified
during pHPT imaging.
Thyroid incidentalomas
Ogawa et al. [11] have highlighted the high prevalence of
thyroid disease in patients with hyperparathyroidism;
10.6 % of their patients had malignant thyroid tumours
detected incidentally on ultrasound. A prospective co-
hort study by Adler et al. in 2010 [5] investigated the
presence of thyroid pathology amongst 310 patients
undergoing ultrasound for pHPT. Of the study popula-
tion, 29 % had an incidental thyroid lesion identified at
the time of ultrasound. The study demonstrated that
approximately 2 % of all patients with pHPT undergoing
an ultrasound had a thyroid malignancy.
In our study, only 6.5 % had a thyroid nodule that
merited further imaging or intervention. Only one pa-
tient had an incidental papillary microcancer on hist-
ology within a colloid nodule detected on an ultrasound
scan; this is considered insignificant.
Breast incidentalomas on nuclear imaging
None of our three patients who had investigations for
increased tracer activity in the breast had a clinically
significant pathology identified. There have been reports
of incidentally detected breast malignancies identified on
imaging. For example, a study of suspicious breast find-
ings in 902 women undergoing PET or CT scans identi-
fied 5 patients with a breast malignancy [13]. There are
also reports that describe the detection of occult breast
cancers in patients undergoing imaging with Tc99m
MIBI [14–16].
Other incidental lesions
Pulmonary nodules are incidental lesions that are fre-
quently identified on imaging for other clinical indications.
The subsequent management and follow-up of these le-
sions is variable and largely dependent on the nodule size,
imaging modality and associated clinical features [17–19].
Wu et al. [20] suggest that small pulmonary nodules in
patients less than 50 years old with no history of malig-
nancy are unlikely to be of clinical significance. The litera-
ture describes the use and high specificity rates of nuclear
imaging, particularly Tc99m MIBI scans, in the evaluation
and management of solitary pulmonary nodules [21].
Our study identified the presence of a pulmonary
nodule on the MIBI scan performed in one patient,
necessitating further investigations.
Our case series identified one patient with increased
bony uptake at the time of MIBI; this was localised to
the clavicle. Qui et al. [22] have described the detection
of vertebral metastases on a MIBI scan, in a patient with
a rare parathyroid carcinoma. Zhao and Wang [23] have
highlighted the relation between a high level of intact
PTH and bone uptake of MIBI, concluding that this
could reflect a stage of metabolic bone disease.
Limitations
The results of this study are limited by the retrospective
nature of the study design, the variability in the manage-
ment of detected incidentalomas and the size of the cohort.
A much larger sample size has the potential to detect clin-
ically significant incidental lesions on parathyroid imaging.
A multicentre study over a longer period of time could
yield more precise estimates of the detection rate of lesions
of clinical significance. This would allow a comprehensive
study of the management practices adopted by different
institutions, analyse the outcomes of the utilised manage-
ment strategies and assist in the development of an appro-
priate management algorithm for such incidentalomas.
Conclusions
The incidence of incidental lesions amongst patients
undergoing localisation studies for pHPT was 10 %. The
clinical significance of these lesions is low. Although larger
studies are required to assess the true clinical impact of
detection of these incidentalomas, the results of this study
serve to provide initial data that addresses the know-
ledge gap regarding the incidence and nature of these
incidental lesions.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SPB was responsible for overseeing the design of the study, data collection,
analysis and critically revising the manuscript. PP was responsible for designing
the study, collecting and interpreting the data and drafting the manuscript. BJH
provided the patient data relevant for the study and critically revised the
manuscript. CC provided the radiology reports on cervical ultrasounds carried out
in the study period and critically revised the manuscript. EL provided the
radiology reports on nuclear imaging of the parathyroid glands in the study
period and critically revised the manuscript. All authors have read and approved
the final manuscript.
Prasad et al. World Journal of Surgical Oncology  (2015) 13:272 Page 4 of 5
Acknowledgements
We thank Mr Ovie Edafe (University of Sheffield Medical School) for assisting
with the SPSS software required for the statistical analysis of the data.
Author details
1Endocrine Surgery Unit, Department of General Surgery, Sheffield Teaching
Hospitals NHS Foundation Trust, Sheffield, UK. 2Department of Radiology,
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. 3Academic
Unit of Surgical Oncology, Department of Oncology, School of Medicine and
Biomedical Sciences, The University of Sheffield, Sheffield S10 2RX, UK.
Received: 20 February 2015 Accepted: 7 September 2015
References
1. Mackenzie-Feder J, Sirrs S, Anderson D, Sharif J, Khan A. Primary
hyperparathyroidism: an overview. Int J Endocrinol. 2011;2011:8. Article ID 251410.
2. Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant III CSM,
et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota,
1993-2001: an update on the changing epidemiology of the disease.
J Bone Miner Res. 2006;21:171–7.
3. Starker LF, Fonseca AL, Carling T, Udelsman R. Minimally invasive
parathyroidectomy. Int J Endocrinol. 2011;2011:Article ID 206502.
4. Sukam A, Rehyan M, Aydin M, Yapar AF, Sert Y, Canpolat T, et al. Preoperative
evaluation of hyperparathyroidism: the role of dual-phase parathyroid
scintigraphy and ultrasound imaging. Ann Nucl Med. 2008;22:123–31.
5. Adler JT, Chen H, Schaefer S, Sippel RS. Does routine use of ultrasound result in
additional thyroid procedures in patients with primary hyperparathyroidism?
J Am Coll Surg. 2010;211:536–9.
6. Carling T, Udelsman R. Focused approach to parathyroidectomy.
World J Surg. 2008;32(7):1512–7.
7. Grant CS, Thompson G, van Farley D, Heerden J. Primary
hyperparathyroidism surgical management since the introduction of
minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg.
2005;140(5):472–9.
8. Kwon JH, Kim EK, Lee HS, Moon HJ, Kwak JY. Neck ultrasonography as
preoperative localization of primary hyperparathyroidism with an additional
role of detecting thyroid malignancy. Eur J Radiol. 2013;82(1):e17–21.
9. Rio PD, Vicente D, Maestroni U, Totaro A, Pattacini GM, Avital I, et al.
A comparison of minimally invasive video-assisted parathyroidectomy and
traditional parathyroidectomy for parathyroid adenoma. J Cancer Educ.
2013;4(6):458–63.
10. Rubello D, Kapse N, Grassetto G, Massaro A, Al-Nahhas A. Minimally invasive
radio-guided surgery for primary hyperparathyroidism: from preoperative to
intraoperative localization imaging. Ann Endocrinol (Paris). 2010;71(6):511–8.
11. Ogawa T, Kammori M, Tsuji E, Kanauchi H, Kurabayashi R, Terada K, et al.
Preoperative evaluation of thyroid pathology in patients with primary
hyperparathyroidism. Thyroid. 2007;17(1):59–62.
12. Milas M, Mensah A, Alghoul M, Berber E, Stephen A, Siperstein A, et al.
The impact of office neck ultrasonography on reducing unnecessary thyroid
surgery in patients undergoing parathyroidectomy. Thyroid. 2005;15(9):1055–9.
13. Beatty JS, Williams HT, Gucwa AL, Hughes MP, Vasudeva VS, Aldridge BA, et al.
The predictive value of incidental PET/CT findings suspicious for breast cancer
in women with non-breast malignancies. Am J Surg. 2009;198(4):495–9.
14. Hod N, Mindlin L, Horne T. Detection of occult breast carcinoma during
evaluation of a skeletal tumor by Tc-99m MIBI scintigraphy. Isr Med Assoc J.
2003;5(4):296–7.
15. Seker D, Seker G, Ozturk E, Bayar B, Kulacoglu H. An incidentally detected
breast cancer on tc-99m MIBI cardiac scintigraphy. J Breast Cancer.
2012;15(2):252–4.
16. García-Talavera P, Olmos R, Sainz-Esteban A, Ruiz MÁ, González ML,
Gamazo C. Evaluation by SPECT-CT of an incidental finding of a thymoma
and breast cancer in a myocardial perfusion SPECT with 99mTc-MIBI.
Rev Esp Med NuclImagen Mol. 2013;32(4):260–2.
17. Madani A, Spicer J, Alcindor T, David M, Vanhuyse M, Asselah J, et al.
Clinical significance of incidental pulmonary nodules in esophageal cancer
patients. J Gastrointest Surg. 2014;18(2):226–33.
18. Blagev DP, Lloyd JF, Conner K, Dickerson J, Adams D, Stevens SM, et al.
Follow-up of incidental pulmonary nodules and the radiology report.
J Am Coll Radiol. 2014;11(4):378–83.
19. Alpert JB, Fantauzzi JP, Melamud K, Greenwood H, Naidich DP, Ko JP.
Clinical significance of lung nodules reported on abdominal CT. Am J Roentgenol.
2012;198(4):793–9.
20. Wu CC, Cronin CG, Chu JT, Halpern EF, Sahani DV, Shepard JA, et al.
Incidental pulmonary nodules detected on abdominal computed
tomography. J Comput Assist Tomogr. 2012;36(6):641–5.
21. Minai OA, Raja S, Mehta AC, Sullivan EJ, Khan SU, Dasgupta A, et al.
Role of Tc-99m MIBI in the evaluation of single pulmonary nodules:
a preliminary report. Thorax. 2000;55(1):60–2.
22. Qiu ZL, Wu CG, Zhu RS, Xue YL, Luo QY. Unusual case of solitary
functioning bone metastasis from a “parathyroid adenoma”: imagiologic
diagnosis and treatment with percutaneous vertebroplasty—case report
and literature review. J Clin Endocrinol Metab. 2013;98(9):3555–61.
23. Zhao Y, Wang Q. Bone uptake of Tc-99m MIBI in patients with
hyperparathyroidism. Ann Nucl Med. 2014;28(4):349–55.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Prasad et al. World Journal of Surgical Oncology  (2015) 13:272 Page 5 of 5
